Who owns Ovid Therapeutics?
- Ticker: OVID
- CUSIP Number: 690469101
Tip: Access positions for across all investors
Analyze quarterly positions in Ovid Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Ovid Therapeutics stock
Who bought or sold Ovid Therapeutics this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| RA Capital Management | 11M | $18M | 100% | Dec 2025 |
|
| Affinity Asset Advisors | 7.2M | $12M | 170% | Dec 2025 |
|
| ADAR1 Capital Management | 4.3M | $7.0M | 33257% | Dec 2025 |
|
| Eventide Asset Management | 4.3M | $7.0M | 100% | Dec 2025 |
|
| Federated Investors | 3.6M | $5.3M | 100% | Dec 2025 |
|
| Point72 Asset Management | 3.6M | $5.8M | 100% | Dec 2025 |
|
| Adage Capital Partners GP | 3.5M | $5.7M | 159% | Dec 2025 |
|
| Vanguard Group | 3.1M | $5.0M | 9% | Dec 2025 |
|
| Saturn V Capital Management | 2.5M | $4.1M | 100% | Dec 2025 |
|
| Ally Bridge Group | 1.8M | $2.9M | 100% | Dec 2025 |
|
| Renaissance Technologies | 1.5M | $2.4M | -26% | Dec 2025 |
|
| Sio Capital Management | 1.4M | $2.3M | 0% | Dec 2025 |
|
| Millennium Management | 1.3M | $2.2M | 36% | Dec 2025 |
|
| Marshall Wace | 1.3M | $2.1M | 62% | Dec 2025 |
|
| Acadian Asset Management | 1.2M | $2.0M | -46% | Dec 2025 |
|
| Citadel Advisors | 921k | $1.5M | 69% | Dec 2025 |
|
| AWM Investment Company | 899k | $1.5M | 100% | Dec 2025 |
|
| Jane Street | 884k | $1.4M | 271% | Dec 2025 |
|
| Wells Fargo & Company | 721k | $1.2M | -1% | Dec 2025 |
|
| Geode Capital Management | 672k | $1.1M | 4% | Dec 2025 |
|
| Assenagon Asset Management | 618k | $1.0M | -33% | Dec 2025 |
|
| BlackRock | 614k | $1000k | 0% | Dec 2025 |
|
| Two Sigma Investments | 599k | $976k | 76% | Dec 2025 |
|
| Walleye Trading Advisors | 530k | $864k | -11% | Dec 2025 |
|
| Susquehanna International | 368k | $600k | -43% | Dec 2025 |
|
| Balyasny Asset Management | 325k | $530k | -48% | Dec 2025 |
|
| State Street Corporation | 277k | $451k | 22% | Dec 2025 |
|
| Ikarian Capital | 248k | $404k | -77% | Dec 2025 |
|
| Two Sigma Advisers | 239k | $390k | 58% | Dec 2025 |
|
| Parkman Healthcare Partners | 201k | $328k | -1% | Dec 2025 |
|
| UBS Group | 193k | $315k | -19% | Dec 2025 |
|
| Schonfeld Strategic Advisors | 193k | $314k | -78% | Dec 2025 |
|
| XTX Topco | 189k | $307k | 3% | Dec 2025 |
|
| Goldman Sachs Group | 171k | $278k | 498% | Dec 2025 |
|
| Northern Trust | 167k | $272k | 10% | Dec 2025 |
|
| Velan Capital Investment Management | 160k | $261k | 0% | Dec 2025 |
|
| Boothbay Fund Management | 156k | $254k | -68% | Dec 2025 |
|
| Graham Capital Management | 128k | $208k | 100% | Dec 2025 |
|
| OMERS Administration Corporation | 125k | $204k | 100% | Dec 2025 |
|
| GSA Capital Partners | 108k | $177k | -59% | Dec 2025 |
|
| Stonepine Capital Management | 102k | $167k | 100% | Dec 2025 |
|
| Bridgeway Capital Management | 95k | $156k | 0% | Dec 2025 |
|
| Quadrature Capital | 88k | $143k | 100% | Dec 2025 |
|
| Bank of New York Mellon | 58k | $94k | 0% | Dec 2025 |
|
| Qube Research & Technologies | 54k | $88k | 113% | Dec 2025 |
|
| FMR | 44k | $72k | -6% | Dec 2025 |
|
| Squarepoint Ops | 39k | $64k | -66% | Dec 2025 |
|
| Invesco | 33k | $54k | 100% | Dec 2025 |
|
| Simplex Trading | 32k | $52k | -92% | Dec 2025 |
|
| Abel Hall | 31k | $51k | -3% | Dec 2025 |
|
| LPL Financial | 30k | $49k | 150% | Dec 2025 |
|
| Total Clarity Wealth Management | 29k | $47k | 100% | Dec 2025 |
|
| William Blair $ Company | 26k | $43k | 5% | Dec 2025 |
|
| First Manhattan | 26k | $42k | 0% | Dec 2025 |
|
| Benin Management Corp | 19k | $42k | 0% | Mar 2026 |
|
| Cetera Investment Advisers | 17k | $28k | 0% | Dec 2025 |
|
| Quadcap Wealth Management | 15k | $25k | 0% | Dec 2025 |
|
| Nine Masts Capital | 14k | $23k | 100% | Dec 2025 |
|
| TLS Advisors | 14k | $374k | -28% | Dec 2025 |
|
| Allspring Global Investments Holdings | 11k | $19k | 0% | Dec 2025 |
|
| Aaron Wealth Advisors | 11k | $18k | 0% | Dec 2025 |
|
| Tower Research Capital | 11k | $17k | 355% | Dec 2025 |
|
| Sepio Capital | 10k | $17k | 100% | Dec 2025 |
|
| Sovereign Financial Group | 10k | $16k | 0% | Dec 2025 |
|
| Rockefeller Capital Management | 4.0k | $6.5k | 100% | Dec 2025 |
|
| Hartland & Co | 2.7k | $4.5k | 100% | Dec 2025 |
|
| NISA Investment Advisors | 2.4k | $3.8k | 0% | Dec 2025 |
|
| Union Bankshares | 2.3k | $3.7k | 0% | Dec 2025 |
|
| North Star Investment Management | 1.0k | $1.7k | 0% | Dec 2025 |
|
| TFC Financial Management | 1.0k | $1.6k | 100% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 980.00 | $1.6k | 2% | Dec 2025 |
|
| Pnc Financial Services | 903.00 | $1.5k | 0% | Dec 2025 |
|
| Fortitude Family Office | 312.00 | $693.014400 | 100% | Mar 2026 |
|
| SBI Securities | 189.00 | $307.994400 | -56% | Dec 2025 |
|
| SRS Capital Advisors | 57.00 | $93.001200 | -59% | Dec 2025 |
|
| SageView Advisory Group | 44.00 | $72.001600 | 100% | Dec 2025 |
|
| TD Waterhouse Canada | 30.00 | $48.999000 | 0% | Dec 2025 |
|
| Sound Income Strategies | 6.00 | $9.000000 | 0% | Dec 2025 |
|
| Barclays | 1.00 | $2.000000 | -99% | Dec 2025 |
|
Who sold out of Ovid Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Driehaus Capital Management | Sep 2025 | 1.4M | $1.8M |
| Kennedy Capital Management | Sep 2025 | 1.1M | $1.4M |
| Group One Trading | Sep 2025 | 188k | $245k |
| Diadema Partners | Sep 2025 | 188k | $244k |
| Empowered Funds | Sep 2025 | 91k | $119k |
| Integrated Wealth Concepts | Sep 2025 | 53k | $69k |
| Persistent Asset Partners | Sep 2025 | 46k | $60k |
| Apollon Wealth Management | Sep 2025 | 28k | $36k |
| Private Advisor | Sep 2025 | 26k | $33k |
| Two Sigma Securities | Sep 2025 | 12k | $15k |
| Advisory Services Network | Sep 2025 | 219.00 | $285.006600 |
| Tradewinds Capital Management | Dec 2025 | 100.00 | $163.000000 |
| CWM | Sep 2025 | 23.00 | $0 |
| Advisor Group Holdings | Sep 2025 | 5.00 | $6.000000 |